您的位置: 首页 > 农业专利 > 详情页

PROCESS OF MANUFACTURING VIRAL VACCINES IN SUSPENSION AVIAN EMBRYONIC DERIVED STEM CELL LINES
专利权人:
发明人:
申请号:
EP06743284.9
公开号:
EP1874918B1
申请日:
2006.04.11
申请国别(地区):
EP
年份:
2015
代理人:
摘要:
Avian, diploid cell lines, EBx, that are non-tumorigenic, immortal and non-transformed are new. Avian, diploid cell lines, EBx, that are non-tumorigenic, immortal and non-transformed are new. They are characterized by: the round, compact morphology of avian embryonal stem cells with high nucleus:cytoplasm ratio population doubling time 15-30, preferably 16-24, hours endogenous alkaline phosphatase and telomerase activities and reaction with antibodies specific for: (i) the markers SSEA-1 (TEC01) and EMA-1 and (ii) cell-surface receptors that contain the oligosaccharides SAalpha 2-3 and SAalpha 2-6. Independent claims are also included for the following: (1) method for producing influenza virus (IV) by replication in EBx (2) method for producing a viral vaccine from IV prepared by method (1) (3) method for preparing antigenic surface proteins (A) from intact IV, prepared by method (1) and (4) vaccines against influenza, killed or live, prepared either by method (2) or from (A). ACTIVITY : Virucide. No details of tests for virucidal activity are given. MECHANISM OF ACTION : Vaccine.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充